CYP2C9 polymorphisms and CYP2C9*2 genotyping primers

被引：6

作者：

Goldstein, JA ^{[1
]}

机构：

[1] NIEHS, Res Triangle Pk, NC 27709 USA

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2002年 / 53卷 / 04期

关键词：

D O I：

10.1046/j.1365-2125.2002.01572_7.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：409 / 410

页数：2

共 7 条

[1] The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase [J].

Crespi, CL ;

Miller, VP .

PHARMACOGENETICS, 1997, 7 (03) :203-210

[2] Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans [J].

Dickmann, LJ ;

Rettie, AE ;

Kneller, MB ;

Kim, RB ;

Wood, AJJ ;

Stein, CM ;

Wilkinson, GR ;

Schwarz, UI .

MOLECULAR PHARMACOLOGY, 2001, 60 (02) :382-387

[3] Stereoselective 4'-hydroxylation of phenytoin: Relationship to (S)-mephenytoin polymorphism in Japanese [J].

Ieiri, I ;

Mamiya, K ;

Urae, A ;

Wada, Y ;

Kimura, M ;

Irie, S ;

Amamoto, T ;

Kubota, T ;

Yoshioka, S ;

Nakamura, K ;

Nakano, S ;

Tashiro, N ;

Higuchi, S .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (04) :441-445

[4] Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin [J].

Kidd, RS ;

Curry, TB ;

Gallagher, S ;

Edeki, T ;

Blaisdell, J ;

Goldstein, JA .

PHARMACOGENETICS, 2001, 11 (09) :803-808

[5] The role of the CYP2C9-Leu(359) allelic variant in the tolbutamide polymorphism [J].

SullivanKlose, TH ;

Ghanayem, BI ;

Bell, DA ;

Zhang, ZY ;

Kaminsky, LS ;

Shenfield, GM ;

Miners, JO ;

Birkett, DJ ;

Goldstein, JA .

PHARMACOGENETICS, 1996, 6 (04) :341-349

[6] DETECTION OF CYP2C9 POLYMORPHISM BASED ON THE POLYMERASE CHAIN-REACTION IN CHINESE [J].

WANG, SL ;

HUANG, JD ;

LAI, MD ;

TSAI, JJ .

PHARMACOGENETICS, 1995, 5 (01) :37-42

[7] Validation of methods for CYP2C9 genotyping:: Frequencies of mutant alleles in a Swedish population [J].

Yasar, Ü ;

Eliasson, E ;

Dahl, ML ;

Johansson, I ;

Ingelman-Sundberg, M ;

Sjoqvist, F .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 254 (03) :628-631

← 1 →